TSX:DOL • CA25675T1075
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DOLLARAMA INC (DOL.CA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-12 | ARC INDEPENDENT RESEARCH | Maintains | Hold -> Hold |
| 2025-12-12 | Veritas Investment Research | Maintains | Buy -> Buy |
| 2025-04-06 | CIBC Capital Markets | Maintains | Neutral -> Neutral |
| 2025-04-06 | Veritas Investment Research | Maintains | Buy -> Buy |
| 2023-08-29 | National Bank Financial | Maintains | Outperform -> Outperform |
| 2022-12-08 | Stifel Nicolaus Research | Upgrade | |
| 2022-12-08 | RBC Royalbank | Upgrade | Outperform |
| 2022-12-08 | National Bank of Canada Financial | Upgrade | Outperform |
| 2022-12-08 | TD Research | Upgrade | Hold |
| 2022-12-08 | CIBC Capital Markets | Upgrade | Neutral |
| 2022-12-08 | Wells Fargo | Upgrade | |
| 2022-12-07 | CIBC Capital Markets | Maintains | Neutral |
| 2022-12-01 | Scotiabank Capital | Maintains | Outperform |
| 2022-12-01 | STA Research | Maintains | Buy |
| 2022-11-30 | National Bank of Canada Financial | Upgrade | |
| 2022-11-29 | Stifel Nicolaus Research | Maintains | Buy |
| 2022-11-17 | TD Research | Downgrade | Buy |
| 2022-11-17 | STA Research | Downgrade | Buy |
| 2022-11-16 | TD Research | Downgrade | |
| 2022-10-18 | STA Research | Maintains | Underperform |
| 2022-10-03 | Scotiabank Capital | Upgrade | Outperform |
| 2022-09-27 | Stifel Nicolaus Research | Maintains | Buy |
| 2022-09-27 | STA Research | Maintains | Underperform |
| 2022-09-12 | Stifel Nicolaus Research | Upgrade | |
| 2022-09-12 | National Bank of Canada Financial | Upgrade | Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.053B 16.67% | 5.867B 16.12% | 6.413B 9.30% | 7.307B 13.94% | 8.182B 11.97% | 8.751B 6.95% | 9.452B 8.01% | 9.941B 5.17% | 10.611B 6.74% | 11.362B 7.08% | 12.17B 7.11% | |
| EBITDA YoY % growth | 1.479B 18.00% | 1.786B 20.71% | 1.992B 11.54% | 2.41B 20.99% | 2.664B 10.54% | 2.898B 8.78% | 3.229B 11.42% | 3.672B 13.72% | 4.064B 10.68% | 4.534B 11.56% | 5.083B 12.11% | |
| EBIT YoY % growth | 1.148B 20.07% | 1.42B 23.76% | 1.581B 11.29% | 1.925B 21.78% | 2.122B 10.23% | 2.314B 9.05% | 2.738B 18.32% | N/A | N/A | N/A | N/A | |
| Operating Margin | 22.71% | 24.21% | 24.65% | 26.34% | 25.93% | 26.44% | 28.97% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 2.76 25.45% | 3.56 28.99% | 4.17 17.13% | 4.73 13.32% | 5.33 12.86% | 6.02 12.88% | 6.98 16.00% | 8.48 21.51% | 9.71 14.41% | 11.20 15.42% | 13.03 16.27% |
All data in CAD
| Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.05 10.80% | 1.33 14.45% | 1.32 12.89% | 1.64 15.75% | 1.20 14.18% | 1.53 14.88% | 1.56 17.76% | 1.86 13.50% |
| Revenue Q2Q % growth | 1.852B 21.75% | 2.047B 18.75% | 2.074B 8.62% | 2.276B 9.40% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 559.86M 25.67% | 660.71M 2.09% | 661.27M -14.31% | 777.89M 11.22% | 625.74M 11.77% | 740.12M 12.02% | 750.4M 13.48% | 858.16M 10.32% |
| EBIT Q2Q % growth | 443.66M 27.32% | 532.38M 19.60% | 525.36M 19.73% | 642.9M 12.58% | N/A | N/A | N/A | N/A |
All data in CAD
20 analysts have analysed DOL.CA and the average price target is 221.48 CAD. This implies a price increase of 31.18% is expected in the next year compared to the current price of 168.84.
The consensus EPS estimate for the next earnings of DOLLARAMA INC (DOL.CA) is 1.05 CAD and the consensus revenue estimate is 1.85B CAD.
The number of analysts covering DOLLARAMA INC (DOL.CA) is 20.